This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Trk receptors | |
|---|---|
| Name | Trk receptors |
| Type | Receptor tyrosine kinase |
| Gene | NTRK1, NTRK2, NTRK3 |
Trk receptors are a family of receptor tyrosine kinases that mediate responses to neurotrophins and regulate neuronal survival, differentiation, and synaptic plasticity. They connect extracellular signals to intracellular cascades that influence development and function in the Cerebral cortex, Spinal cord, Hippocampus, and peripheral nervous system structures such as the Dorsal root ganglion and Sympathetic nervous system. Trk receptors are implicated in human conditions studied in contexts like the World Health Organization public health initiatives and clinical research at institutions including National Institutes of Health and Mayo Clinic.
Trk receptors comprise three principal members encoded by the genes NTRK1, NTRK2, and NTRK3, discovered during investigations of neurotrophin signaling contemporaneous with research by teams at Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, and Massachusetts Institute of Technology. Early work connecting neurotrophins such as nerve growth factor to cognate receptors referenced models developed at Max Planck Society and collaborations with laboratories at University of California, San Francisco and Stanford University. Their identification informed translational studies at centers including Johns Hopkins University and pharmaceutical programs at GlaxoSmithKline and Novartis.
Each Trk receptor contains an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular tyrosine kinase domain homologous to other receptor tyrosine kinases characterized in studies at Salk Institute and European Molecular Biology Laboratory. Alternative splicing produces isoforms with variable intracellular C-terminal tails; notable isoforms include full-length catalytic variants and truncated forms lacking kinase activity, cataloged in genomic resources curated by National Center for Biotechnology Information and annotated in databases maintained by Ensembl and UniProt. Structural investigations using crystallography at facilities such as Diamond Light Source and cryo-electron microscopy at European Synchrotron Radiation Facility resolved ligand-bound conformations, informing comparisons with kinases studied in the context of Ras family and Src family research programs.
TrkA, TrkB, and TrkC selectively bind the neurotrophins NGF, BDNF/NT-4/5, and NT-3 respectively, as demonstrated in biochemical assays developed at Cold Spring Harbor Laboratory and binding studies conducted at Max Planck Institute for Brain Research. Ligand specificity is determined by extracellular immunoglobulin-like and leucine-rich repeat motifs; cross-reactivity such as NT-3 activation of TrkA or TrkB occurs under certain co-receptor contexts described in work from University College London and Karolinska Institutet. Interactions with co-receptors including p75NTR (NGFR) and sortilin influence affinity and downstream outcomes, topics explored in collaborative projects with investigators at Imperial College London and University of Cambridge.
Activation of Trk receptors triggers autophosphorylation of intracellular tyrosines and recruitment of adaptor proteins such as Shc, FRS2, and PLCγ, initiating canonical cascades including the MAPK/ERK, PI3K/AKT, and PLCγ–PKC pathways. These signaling modules intersect with pathways studied in oncology and cell biology at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center, where parallels between Trk-driven survival signaling and receptor tyrosine kinase oncogenes were delineated. Retrograde transport of activated Trk complexes along microtubules engages motor proteins characterized in research at Rockefeller University and influences transcriptional programs via effectors like CREB and NF-κB, topics pursued at Harvard Medical School and University of Pennsylvania.
Trk receptor signaling controls neuronal survival during development in model organisms used at Cold Spring Harbor Laboratory and Max Planck Society facilities, mediates axon guidance and dendritic arborization in systems studied at University of California, Berkeley, and regulates synaptic plasticity underlying learning and memory processes investigated at Massachusetts Institute of Technology and Stanford University. Peripheral roles include modulation of nociception and autonomic function assessed in clinical and preclinical studies at Mayo Clinic and University of Michigan. Trk-dependent mechanisms also contribute to sensory organ development such as auditory and visual systems explored at Johns Hopkins University School of Medicine and Basel University.
Genetic alterations, including point mutations and gene fusions involving NTRK genes, have been identified in congenital insensitivity to pain with anhidrosis, various pediatric and adult cancers, and neurodevelopmental disorders; these findings emerged from genomic consortia like The Cancer Genome Atlas and sequencing efforts at Wellcome Sanger Institute. NTRK gene fusions are actionable targets in oncology with therapeutics developed by companies such as Bayer and Loxo Oncology; clinical trials and regulatory approvals overseen by agencies like the Food and Drug Administration and European Medicines Agency informed targeted inhibitor use. Dysregulation of TrkB signaling has been implicated in psychiatric conditions studied at National Institute of Mental Health and neurodegenerative diseases researched at Alzheimer's Disease Research Center programs.
Research employs molecular genetics techniques such as CRISPR–Cas9 genome editing refined at Broad Institute and transgenic models generated at centers including Jackson Laboratory and Cincinnati Children's Hospital. Biochemical tools include ligand-binding assays, phospho-specific antibodies produced by vendors collaborating with laboratories at Cold Spring Harbor Laboratory, and kinase activity assays standardized in protocols from Addgene and Nature Protocols. Imaging of Trk trafficking uses live-cell microscopy platforms developed at European Molecular Biology Laboratory and super-resolution methods advanced at Howard Hughes Medical Institute. High-throughput sequencing and proteomics pipelines from National Center for Biotechnology Information and ProteomeXchange support discovery of NTRK alterations in clinical samples.
Category:Receptor tyrosine kinases